José [de Jesús] Ortiz, MD, FACC
Assistant Professor of Medicine-Cardiology
Heart Failure-Heart transplant team physician

University Hospitals of Cleveland andLouis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio


 
1980 - 1985 
 MD Degree, Universidad del Norte, Barranquilla, Columbia, a, South America.
1987 - 1990
 Internal Medicine Residency. Hospital de Clinicas, Montevideo, Uruguay, South America.
1990 - 1993
 Cardiac Electrophysiology Research Fellow. University Hospitals of Cleveland, Cleveland, Ohio
1994 - 1995  Internal Medicine Residency. University Hospitals of Cleveland, Cleveland, Ohio
1996 - 1998  Cardiology Fellowship Program. University Hospitals of Cleveland, Cleveland, Ohio

APPOINTMENTS:
 
12/84 -  12/85  Intern: Instituto de Seguros Sociales, Barranquilla, Colombia; Dr. Jaime Daza, Supervisor.
  2/86 -    2/87  Social Service Year: Hospital de Sabanalarga, Sabanalarga, Colombia; Dr. Jesus Sarmiento, Supervisor.
  3/87 -    8/90  Internal Medicine Post Graduate: Hospital de Clinicas, Montevideo, Uruguay; Dr. Milton Portos, Supervisor.
  9/90 -  12/93  Electrophysiology Research Fellow: University Hospitals of Cleveland, Cleveland, Ohio; Albert L. Waldo, M.D., Supervisor
  1/94 -  12/95  Internal Medicine Resident: University Hospitals of Cleveland, Cleveland, Ohio; Dr. Keith B. Armitage, Program Director.
  1/96 -    6/98   Cardiology Fellow: University Hospitals of Cleveland, Cleveland, Ohio; Dr. Jonathan S. Scharfstein and Dr. Frank V. Brozovich, Program Directors.
  7/98 -   present  Staff Cardiologist. Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio
  3/99 -   present   Pharmacy and Therapeutics Committee. Medical Service Representative. Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio
  6/99 -   present   Associate Director Cardiac Intensive Care Unit / Medical Intensive Care Unit. Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland,   Ohio
   6/99 -  present  Director Cardiac Intensive Care Unit. Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio
   7/99 -  present   Director Cardiology Clinic. Louis Stokes Brecksville Department of Veterans Affairs Medical Center, Brecksville, Ohio
   9/99 -  present  Assistant Professor of Medicine-Cardiology. Case Western Reserve University, University Hospitals of Cleveland, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland Ohio.
  1/00 -   present  Heart Failure-Heart transplant team physician. University Hospitals of Cleveland, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland Ohio

ONGOING CLINICAL RESEARCH TRIALS:

1. CARP: “The Coronary Artery Revascularization Prophylaxis Trial”. VA Cooperative Study #411. Co-Investigator for the Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio.

2. CHARM: “Candesartan Cilexitil in Heart failure Assessment of Reduction in Mortality and morbidity”. International Multicenter Trial. Co-Investigator for the Louis Stokes Cleveland Department of Veterans Affairs Medical Center. Sub-investigator for the University Hospitals of Cleveland, Cleveland, Ohio.

3. PEACE: “ Prevention of Events with Angiotensin Converting Enzyme inhibition”. International Multicenter Trial. Co-Investigator for the Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio.

4. WATCH: “Warfarin and Antiplatelet Therapy in Chronic Heart failure trial. VA Cooperative study. Co-Investigator for the Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio.  Sub-investigator for the University Hospitals of Cleveland, Cleveland, Ohio.

5. STICH. Surgical Treatment of Ischemic Congestive Heart Failure Trial. Co-Investigator for the University Hospitals of Cleveland, Cleveland, Ohio.

6. CRUSADE. Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation of the ACC/AHA Guidelines. Principle Investigator for the Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio.
 

7. ROOBY. Studies Program (CSP) # 517. Revascularization On and Off cardiopulmonary BYpass. Co-Investigator for the Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio

8. A-Heft. African-American Heart Failure Trial. A Placebo-controlled trial of Bidil® added to Standard Therapy in African-American patient with Heart Failure.  Sub-investigator for the Louis Stokes Cleveland Department of Veterans Affairs Medical Center and for the University Hospitals of Cleveland, Cleveland, Ohio.

9. Combretastatin in anaplastic thyroid cancer. (ICC 2302). Cardiology consultant. University Hospitals of Cleveland, Ireland Cancer Center. Cleveland, Ohio.

10. ESCAPE. Evaluation Study of Congestive Heart Failure And Pulmonary Artery Catheterization Effectiveness. Sub-investigator for the University Hospitals of Cleveland, Cleveland, Ohio.

11. REVIVE. Randomized Evaluation of Intravenous leVosimendan. Efficacy versus Placebo in the Short term treatment of decompensated chronic heart failure. Sub-investigator for the University Hospitals of Cleveland, Cleveland, Ohio.

PEER REVIEWED MANUSCRIPTS:

1. ORTIZ J, Salas J, Portos M: Lupus eritematoso sistémico y manifestaciones cardiovasculares. Archivos de Medicina Interna. XII; 3: 117?124, 1990

2. ORTIZ J, Igarashi M, Gonzalez HX, Laurita K, Rudy Y, Waldo AL:  Mechanism of spontaneous termination of stable atrial flutter in the canine sterile pericarditis model.  Circulation. 1993;88[part 1]:1866-1877

3. ORTIZ J, Nozaki A, Shimizu A, Khrestian C, Rudy Y, Waldo AL:  Mechanism of interruption of atrial flutter by moricizine:  Electrophysiological and multiplexing studies in the canine sterile pericarditis model of atrial flutter.  Circulation. 1994;89:2860-2869

4. ORTIZ J, Niwano S, Abe H, Gonzalez HX, Rudy Y, Johnson NJ, Waldo AL:  Mapping the conversion of atrial flutter to atrial fibrillation and atrial fibrillation to atrial flutter - Insights into mechanism. Circ Res. 1994;74:882-894

5. Niwano S, ORTIZ J, Abe H, Gonzalez X, Rudy Y, Waldo AL: Characterization of the excitable gap in a functionally determined reentrant circuit- Studies in the sterile pericarditis model of atrial flutter.  Circulation. 1994;90:1997-2014

6. ORTIZ J, Sokoloski MC, Ayers GM, Cmolik BL, Niwano S, Geha AS, Waldo AL:  Atrial defibrillation using temporary epicardial defibrillation stainless steel wire electrodes- Studies in the canine sterile pericarditis model. J Am Coll Cardiol 1995;26:1356-64.

7. Cmolik BL, ORTIZ J, Ayers GM, Lee JL, Geha AS, Waldo AL:  Successful atrial defibrillation with very-low-energy shocks by means of temporary epicardial wire electrodes. J Thorac Cardiovasc Surg 1996;111:392-8.

8. Cmolik BL, ORTIZ J, Ayers GM, Lee JL, Geha AS, Waldo AL:  Successful atrial defibrillation with very-low-energy shocks by means of temporary epicardial wire electrodes. J Thorac Cardiovasc Surg 1996;111:392-8.

9. Hamza, N, ORTIZ J, Bonomo RA: Isolated Pulmonic Valve-Infective Endocarditis: A persistent Challenge. Infection 2003. In press
 
 

ABSTRACTS:

1. Vanzini P, Freire D, ORTIZ J, Arbiza T:  Tests no invasivos vinculados con refractariedad de la via accesoria en el Sindrome de Wolff-Parkinson-White. Rev Soc Uruguaya de Cardiología. 1989; IV.

2. ORTIZ J, Igarashi M, Gonzalez X, Laurita K, Rudy Y, Waldo AL:  Mechanism of spontaneous termination of atrial flutter in the canine pericarditis model.  PACE. 1991; 14:627.

3. ORTIZ J, Igarashi M, Gonzalez X, Waldo AL, Johnson NJ: Mechanism of atrial flutter termination by WAY?123,398, a unique class III agent. Circulation 1991; 84:II?507.

4. ORTIZ J, Igarashi M, Gonzalez X, Laurita K, Johnson NJ, Waldo AL: Does the sinus node participate in the genesis of new wave fronts during atrial fibrillation in the canine pericarditis model?.  J Am Coll Cardiol; 19:90A, 1992.

5. Igarashi M, ORTIZ J, Gonzalez X, Waldo AL: Termination and reinduction of atrial flutter after Moricizine and N?acetylprocainamide in the canine pericarditis model.  PACE; 15:528, 1992.

6. Rizk H, ORTIZ J, Igarashi M, Gonzalez X, Waldo AL:  Double potentials equals block, not slow conduction.  Circulation; 86:I-751, 1992.

7. ORTIZ J, Igarashi M, Gonzalez X, Johnson NJ, Waldo AL:  A new, reliable atrial fibrillation model with a clinical counterpart.  J Am Coll Cardiol. 1993;21:183A.

8. ORTIZ J, Murthi A, Gonzalez X, Waldo AL:  Studies of collision of wave fronts - Implications for understanding double potentials recorded in reentrant rhythms.  J Am Coll Cardiol. 1993;21:220A.

9. Lieberman RA, ORTIZ J, Biblo LA, Johnson NJ, Carlson MD, Waldo AL:  New clinical index for predictive efficacy of antiarrhythmic drug therapy for ventricular tachycardias.  J Am Coll Cardiol. 1993;21:244A.

10. ORTIZ J, Igarashi M, Gonzalez X, Johnson NJ, Waldo AL:  Prevention of reinduction of atrial flutter by WAY 123,398.  A unique observation. PACE. 1993;16:II-864.

11. Niwano S, ORTIZ J, Abe H, Gonzalez X, Waldo AL:  Evaluation of resetting in a functionally determined reentrant circuit.  PACE. 1993;16:II-864.

12. ORTIZ J, Niwano S, Abe H, Gonzalez X, Johnson NJ, Waldo AL:  Mapping the conversion of atrial flutter to atrial fibrillation and vice versa - Insights into mechanism.  PACE. 1993;16:II-890.

13. ORTIZ J, Niwano S, Abe H, Gonzalez X, Ayers GM, Waldo AL:  Transvenous atrial defibrillation in two canine models of atrial fibrillation. J Am Coll Cardiol. 1994;23:125A.

14. ORTIZ J, Sokoloski MC, Niwano S, Abe H, Gonzalez X, Ayers GM, Alferness CA, Waldo AL:  Successful atrial defibrillation using temporary pericardial electrodes.  J Am Coll Cardiol. 1994;23:125A.

15. Niwano S, ORTIZ J, Abe H, Gonzalez X, Waldo AL:  Effects of rapid pacing on components of a stable, functionally determined reentrant circuit.  J Am Coll Cardiol. 1994;23:283A.

16. Abe H, ORTIZ J, Niwano S, Gonzalez X, Waldo AL:  Effect of an isthmus on anisotropic conduction of atrial myocardium:  A possible model of slow conduction.  J Am Coll Cardiol. 1994;23:467A.

17. ORTIZ J, Sokoloski MC, Niwano S, Ayers GM, Waldo AL: Effects of ß-methacholine on the atria; Implications for understanding atrial fibrillation and transvenous atrial defibrillation.  PACE 1994;17(4):790.

18. Niwano S, Lorber J, ORTIZ J, Gonzalez X, Waldo AL:  Inhomogeneity of excitable gap in a functionally determined atrial flutter reentrant circuit.  PACE 1994;17(4):808.

19. Niwano S, ORTIZ J, Abe H, Gonzalez X, Waldo AL:  Interruption of atrial flutter by a premature beat is not due to refractoriness. PACE 1994;17(4):839.

20. Sokoloski MC, Merkatz KA, ORTIZ J, Gonzalez X, Waldo AL, Johnson NJ:  Subepicardial transmembrane potential changes may contribute to slow conduction in the canine sterile pericarditis model of atrial flutter. PACE 1994;17(4):855.

21. Niwano S, Sokoloski MC, ORTIZ J, Khrestian C, Ayers GM, Waldo AL:  Evaluation of ventricular vulnerability and safety during atrial defibrillation via implanted transvenous catheters in the sterile pericarditis model. Circulation; 90:I-13, 1994.

22. Niwano S, ORTIZ J, Waldo AL:  Surprising effects of antiarrhythmic drugs on the excitable gap in the atrial flutter reentrant circuit of the sterile pericarditis model.  Circulation; 90:I-412, 1994.

23. Niwano S, Sokoloski MC, ORTIZ J, Khrestian C, Ayers GM, Waldo AL:  Effects of digoxin and sotalol on atrial defibrillation thresholds via implanted transvenous catheter electrodes. J AM Coll Cardiol 1995;25:109A.

24. Niwano S, ORTIZ J, Kumagai K, Waldo AL:  Variation of atrial flutter termination by premature beats.  Studies in the sterile pericarditis model.  J Am Coll Cardiol 1995;25:257A.

25. Kumagai K, Niwano S, Khrestian C, ORTIZ J, Waldo AL:  Simultaneous multisite mapping during induced atrial fibrillation in the canine sterile pericarditis model - Insights into self-sustaining mechanisms.  PACE 1995;18(II):809.

26. Eisenberg M, Teng F, Chaudhry M, ORTIZ J, Pilote L: Improved Functional Status and Quality of Life after Invasive Management of Non-ST-Segment Elevation Acute Myocardial Infarction. .  J Am Coll Cardiol 2003;41(6 suppl A):398A.

last updated 10/01/03 plb